Scott Isaacs (@scottisaacsmd) 's Twitter Profile
Scott Isaacs

@scottisaacsmd

President @theaace, endocrinologist, obesity medicine, #MASLD, Emory Med School adjunct faculty. Posts are my own.

ID: 213754594

linkhttp://www.atlantaendocrine.com calendar_today09-11-2010 18:24:54

6,6K Tweet

16,16K Takipçi

2,2K Takip Edilen

Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo
Scott Isaacs
@scottisaacsmd

4 months ago

Meta-analysis of 11 clinical trials showing that GLP-1 receptor agonists significantly reduce the risk of kidney outcomes, major adverse cardiovascular events, and all-cause death, without increasing the risk of serious adverse events such as hypoglycemia and acute pancreatitis.

Meta-analysis of 11 clinical trials showing that GLP-1 receptor agonists significantly reduce the risk of kidney outcomes, major adverse cardiovascular events, and all-cause death, without increasing the risk of serious adverse events such as hypoglycemia and acute pancreatitis.